HOME >> MEDICINE >> NEWS
M. D. Anderson, African-American churches team up for prostate cancer prevention study

HOUSTON - The University of Texas M. D. Anderson Cancer Center is teaming with more than 40 Houston-area African-American churches to encourage men in their congregations to participate in a prostate cancer prevention study, the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

SELECT Sunday - a nationwide effort to increase the number of African-American men enrolled in SELECT - will be launched Sunday, Nov. 16, during morning church services throughout the nation, including more than 40 participating churches in the Houston area.

Elise D. Cook, M.D., M. D. Anderson's SELECT principal investigator, is national chair of the SELECT Minority and Medically Underserved Committee, which conceived the idea of a nationwide SELECT Sunday.

During SELECT Sunday, pastors will speak briefly from their pulpits about SELECT. This event includes distribution of study information in the churches through flyers, revival fans, bulletin announcements, bulletin boards and church Web sites.

SELECT, sponsored by the National Cancer Institute (NCI) and the Southwest Oncology Group (an NCI-supported national research group), is designed to determine whether selenium and vitamin E, or both, can prevent prostate cancer, the third leading cancer killer in men.

Increasing enrollment of African-American men is important because they are more likely to be diagnosed with prostate cancer and are twice as likely to die from the disease than men of any other racial or ethnic background.

"SELECT Sunday was developed to increase enrollment of African-American men because the study is below its national target of 20 percent enrollment for this racial group," Cook says. "For this reason, we are placing a strong emphasis on recruiting African-American men." At 27 percent African-American enrollment, M. D. Anderson has exceeded its 20 percent African-American enrollment goal, and is participating in SELECT Sunday to support reaching the natio
'"/>

Contact: Alison Ruffin
aruffin@mdanderson.org
713-794-1731
University of Texas M. D. Anderson Cancer Center
14-Nov-2003


Page: 1 2

Related medicine news :

1. $15 million grant spurs cancer collaboration; M. D. Anderson, University of Puerto Rico
2. African-American women with endometrial cancer have more aggressive cancer than Caucasian women
3. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
4. Obesity among African-American stroke survivors increases risk factors for recurrent stroke
5. African-Americans receive less aggressive heart attack treatment
6. African-Americans may need more medication to control asthma
7. Good medicine, good economics: African-Americans need equal treatment for pain, SLU study finds
8. Beliefs may hinder HIV prevention among African-Americans
9. Study suggests obesity has lesser financial impact on African-Americans
10. Sobering disparity: African-Americans receive less compensation for job-related back injuries
11. African-American heart attack patients fare worse long term

Post Your Comments:
(Date:4/23/2014)... Cancer Center researchers say clinical trials for a ... (AML) are very promising. Patients treated with CPX-351, ... daunorubicin, are showing better responses than patients treated ... , "Acute myeloid leukemia is an aggressive blood ... especially in older patients," explained Jeffrey Lancet, M.D., ...
(Date:4/23/2014)... The American Society for Radiation Oncology (ASTRO) has ... Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based ... therapy in the treatment of endometrial cancer. The ... 2014 issue of Practical Radiation Oncology ... The full-length guideline is available as an open-access ...
(Date:4/23/2014)... that targets an important brain receptor has a dramatic ... relapse behavior, a University at Buffalo animal study has ... may be a novel lead compound for treating cocaine ... research was published as an online preview article in ... the compound, RO5263397, severely blunted a broad range of ...
(Date:4/23/2014)... that can rapidly screen a large cell population ... that population has been seriously lacking," said Virginia ... Royal Society of Chemistry journal Chemical Science ... coworkers have developed a novel technique that detects ... Sci. , 2014, DOI: 10.1039/C4SC00578C, http://pubs.rsc.org/en/content/articlelanding/2014/sc/c4sc00578c#!divAbstract ). ...
(Date:4/23/2014)... Ill. - In a country as wealthy as the United ... 12 seniors do not have access to adequate food due ... food insecure. , Recent research at the University of ... Survey (NHANES) revealed that the seniors who are dealing with ... , "In 2011, 8.35 percent of Americans over age 60 ...
Breaking Medicine News(10 mins):Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
Cached News: